Vetr Thinks Regeneron Is Looking Healthy
November 21, 2016 at 08:12 AM EST
On Friday, the Vetr crowd upgraded their rating of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from 4 stars (buy), issued two days ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.